StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Just a taste of what's to come

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Apr 12, 2021 4:21pm

133 Views

Post# 32979342

RE:RE:Just a taste of what's to come

$1.5 million in Q3, $3.4 million in Q4 and we have added staff and continued to grow.

It's obvious you are just here to bash and reasonable person would see the growth trajectory and assume $5 million is achievable.

Maybe short it some more and see how that works for you.